|
2.6 ETIOLOGIE - ENVIRONNEMENT
|
|
|
|
3.3 PRÉVENTION - VACCINS
|
|
|
|
4.11 DÉP., DIAG. & PRONO. - OVAIRE
|
|
|
|
4.12 BIOPSIES LIQUIDES
|
|
|
|
5. TRAITEMENTS
|
|
|
Colorectal cancer NICE guideline [NICE]
|
|
|
|
|
|
This guideline covers managing colorectal (bowel) cancer in people aged 18 and over. It aims to improve quality of life and survival for adults with colorectal cancer through management of local disease and management of secondary tumours (metastatic disease).
|
|
|
|
|
|
|
5.1 TRAITEMENTS - PRÉ-CLINIQUE
|
|
|
|
5.10 TRAITEMENTS - ESSAIS
|
|
|
|
5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE
|
|
|
Working to Improve Immunotherapy for Lung Cancer [NIH Director's Blog]
|
|
|
|
|
|
In their mouse experiments, the researchers found that when PD-1 was combined with an existing drug that inhibits neutrophils, lung tumors infiltrated with neutrophils were converted into tumors infiltrated by T cells. The tumors treated with the combination treatment also expressed genes associated with an active immunotherapy response.
|
|
|
|
|
|
|
5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES
|
|
|
|
|
5.2 PHARMA
|
|
|
|
|
|
5.2.3 PHARMA - ÉCONOMIE
|
|
|
|
5.2.6 PHARMA - BIOTECH
|
|
|
|
|
6.1 OBSERVATION
|
|
|
|